106 related articles for article (PubMed ID: 18783494)
1. Clinical and histological aspects of CNV formation: studies in an animal model.
Lassota N
Acta Ophthalmol; 2008 Sep; 86 Thesis 2():1-24. PubMed ID: 18783494
[TBL] [Abstract][Full Text] [Related]
2. Clinical and histological findings after intravitreal injection of bevacizumab (Avastin) in a porcine model of choroidal neovascularization.
Lassota N; Prause JU; Scherfig E; Kiilgaard JF; la Cour M
Acta Ophthalmol; 2010 May; 88(3):300-8. PubMed ID: 19416113
[TBL] [Abstract][Full Text] [Related]
3. Natural history of choroidal neovascularization after surgical induction in an animal model.
Lassota N; Kiilgaard JF; la Cour M; Scherfig E; Prause JU
Acta Ophthalmol; 2008 Aug; 86(5):495-503. PubMed ID: 18752525
[TBL] [Abstract][Full Text] [Related]
4. Surgical induction of choroidal neovascularization in a porcine model.
Lassota N; Kiilgaard JF; Prause JU; Qvortrup K; Scherfig E; la Cour M
Graefes Arch Clin Exp Ophthalmol; 2007 Aug; 245(8):1189-98. PubMed ID: 17219108
[TBL] [Abstract][Full Text] [Related]
5. Optimization of laser-induced choroidal neovascularization in African green monkeys.
Goody RJ; Hu W; Shafiee A; Struharik M; Bartels S; López FJ; Lawrence MS
Exp Eye Res; 2011 Jun; 92(6):464-72. PubMed ID: 21414311
[TBL] [Abstract][Full Text] [Related]
6. A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations.
Algvere PV; Steén B; Seregard S; Kvanta A
Acta Ophthalmol; 2008 Aug; 86(5):482-9. PubMed ID: 18162062
[TBL] [Abstract][Full Text] [Related]
7. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
Chan CK; Meyer CH; Gross JG; Abraham P; Nuthi AS; Kokame GT; Lin SG; Rauser ME; Kaiser PK
Retina; 2007 Jun; 27(5):541-51. PubMed ID: 17558314
[TBL] [Abstract][Full Text] [Related]
8. Time-course of experimental choroidal neovascularization in Dutch-Belted rabbit: clinical and histological evaluation.
Ni M; Holland M; Jarstadmarken H; De Vries G
Exp Eye Res; 2005 Sep; 81(3):286-97. PubMed ID: 16129096
[TBL] [Abstract][Full Text] [Related]
9. Implications of bevacizumab on vascular endothelial growth factor and endostatin in human choroidal neovascularisation.
Tatar O; Shinoda K; Kaiserling E; Claes C; Eckardt C; Eckert T; Pertile G; Boeyden V; Scharioth GB; Yoeruek E; Szurman P; Bartz-Schmidt KU; ; Grisanti S
Br J Ophthalmol; 2009 Feb; 93(2):159-65. PubMed ID: 18838410
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin.
Chan WM; Lai TY; Liu DT; Lam DS
Am J Ophthalmol; 2007 Jun; 143(6):977-983. PubMed ID: 17459318
[TBL] [Abstract][Full Text] [Related]
11. A new animal model of choroidal neovascularization.
Kiilgaard JF; Andersen MV; Wiencke AK; Scherfig E; la Cour M; Tezel TH; Prause JU
Acta Ophthalmol Scand; 2005 Dec; 83(6):697-704. PubMed ID: 16396647
[TBL] [Abstract][Full Text] [Related]
12. Choroidal neovascularization in the rat induced by adenovirus mediated expression of vascular endothelial growth factor.
Baffi J; Byrnes G; Chan CC; Csaky KG
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3582-9. PubMed ID: 11006256
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.
Ladas ID; Kotsolis AI; Papakostas TD; Rouvas AA; Karagiannis DA; Vergados I
Retina; 2007 Sep; 27(7):891-6. PubMed ID: 17891013
[TBL] [Abstract][Full Text] [Related]
14. Bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization in multifocal choroiditis.
Fine HF; Zhitomirsky I; Freund KB; Barile GR; Shirkey BL; Samson CM; Yannuzzi LA
Retina; 2009 Jan; 29(1):8-12. PubMed ID: 18784620
[TBL] [Abstract][Full Text] [Related]
15. Near-infrared autofluorescence in patients with idiopathic submacular choroidal neovascularization.
Toju R; Iida T; Sekiryu T; Saito M; Maruko I; Kano M
Am J Ophthalmol; 2012 Feb; 153(2):314-9. PubMed ID: 21982958
[TBL] [Abstract][Full Text] [Related]
16. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic studies of eyes that were obtained postmortem from four patients who were enrolled in the submacular surgery trials: SST Report No. 16.
Grossniklaus HE; Wilson DJ; Bressler SB; Bressler NM; Toth CA; Green WR; Miskala P
Am J Ophthalmol; 2006 Jan; 141(1):93-104. PubMed ID: 16386982
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks.
Sawa M; Gomi F; Tsujikawa M; Sakaguchi H; Tano Y
Am J Ophthalmol; 2009 Oct; 148(4):584-590.e2. PubMed ID: 19541288
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
Gu L; Chen H; Tuo J; Gao X; Chen L
Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
